H4U-23644-26621
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 974 / OR
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Moderna
-
2021-02-23
Dose 2 — Moderna
-
2021-02-26
Registered in v-safe
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-27
Survey response — days 1–6 daily, dose 2MedDRA: Pyrexia — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: Fever the day of vaccine got up to 103.4MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-11
- 2021-03-16
-
2021-05-25
Survey response — 3 months, dose 2MedDRA: Abnormal uterine bleeding, Uterine dilation and curettage — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Irregular uterine bleeding. · Healthcare visit (other): D&c, hysteroscopyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-25
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-26
- 2022-05-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Moderna | |
| 2 | 2021-02-23 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-25 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Fever the day of vaccine got up to 103.4
Release 8 — 3 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | ✓ | ✓ | ✓ |
| SD | Abnormal uterine bleeding | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release